Up Next

ki-logo-white
Market-Based Solutions to Vital Economic Issues

SEARCH

Research
Nov 30, 2024

The Reality of Medicare Part D Drug Price Negotiations Under the Inflation Reduction Act

CBOH’s Markus Saba, along with Kenan-Flagler Business School students, Tanya Aggarwal, Ashwin Ramanathan, and Stewart Spanbauer, have co-authored an article exploring Medicare Part D drug prices under the IRA.

You may also be interested in: